FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023333753> ?p ?o ?g. }

• W2023333753 endingPage "948" @default.
• W2023333753 startingPage "939" @default.
• W2023333753 abstract "The development of imaging methods to measure changes in NMDA ion channel activation would provide a powerful means to probe the mechanisms of drugs and device based treatments (e.g., ECT) thought to alter glutamate neurotransmission. To provide a potential NMDA/PCP receptor PET tracer, we synthesized the radioligand [11C]GMOM (ki = 5.2 +/-0.3 nM; log P = 2.34) and evaluated this ligand in vivo in awake male rats and isoflurane anesthetized baboons. In rats, the regional brain uptake of [11C]GMOM ranged from 0.75+/-0.13% ID/g in the medulla and pons to 1.15+/-0.17% ID/g in the occipital cortex. MK801 (1 mg/kg i.v.) significantly reduced (24-28%) [11C]GMOM uptake in all regions. D-serine (10 mg/kg i.v.) increased [11C]GMOM %ID/g values in all regions (10-24%) reaching significance in the frontal cortex and cerebellum only. The NR2B ligand RO 25-6981 (10 mg/kg i.v.) reduced [11C]GMOM uptake significantly (24-38%) in all regions except for the cerebellum and striatum. Blood activity was 0.11+/-0.03 %ID/g in the controls group and did not vary significantly across groups. PET imaging in isoflurane-anesthetized baboons with high specific activity [11C]GMOM provided fairly uniform regional brain distribution volume (VT) values (12.8-17.1 ml g(-1)). MK801 (0.5 mg/kg, i.v., n = 1, and 1.0 mg/kg, i.v., n = 1) did not significantly alter regional VT values, indicating a lack of saturable binding. However, the potential confounding effects associated with ketamine induction of anesthesia along with isoflurane maintenance must be considered because both agents are known to reduce NMDA ion channel activation. Future and carefully designed studies, presumably utilizing an optimized NMDA/PCP site tracer, will be carried out to further explore these hypotheses. We conclude that, even though [11C]GMOM is not an optimized PCP site radiotracer, its binding is altered in vivo in awake rats as expected by modulation of NMDA ion channel activity by MK801, D-serine or RO 25-6981. The development of higher affinity NMDA/PCP site radioligands is in progress." @default.
• W2023333753 created "2016-06-24" @default.
• W2023333753 creator A5013653576 @default.
• W2023333753 creator A5016514269 @default.
• W2023333753 creator A5018313627 @default.
• W2023333753 creator A5020722287 @default.
• W2023333753 creator A5029786366 @default.
• W2023333753 creator A5053572621 @default.
• W2023333753 creator A5071624932 @default.
• W2023333753 creator A5083715547 @default.
• W2023333753 creator A5087635866 @default.
• W2023333753 date "2004-10-01" @default.
• W2023333753 modified "2023-10-13" @default.
• W2023333753 title "In vivo evaluation of [11C]N-(2-chloro-5-thiomethylphenyl)-N′- (3-methoxy-phenyl)-N′-methylguanidine ([11C]GMOM) as a potential PET radiotracer for the PCP/NMDA receptor" @default.
• W2023333753 cites W1600539804 @default.
• W2023333753 cites W1972245629 @default.
• W2023333753 cites W1974416557 @default.
• W2023333753 cites W1975275982 @default.
• W2023333753 cites W2006127796 @default.
• W2023333753 cites W2013374077 @default.
• W2023333753 cites W2014557309 @default.
• W2023333753 cites W2016713681 @default.
• W2023333753 cites W2018722303 @default.
• W2023333753 cites W2024677729 @default.
• W2023333753 cites W2032942086 @default.
• W2023333753 cites W2034169246 @default.
• W2023333753 cites W2045515851 @default.
• W2023333753 cites W2047342648 @default.
• W2023333753 cites W2048270362 @default.
• W2023333753 cites W2050207993 @default.
• W2023333753 cites W2051166675 @default.
• W2023333753 cites W2051399142 @default.
• W2023333753 cites W2051809205 @default.
• W2023333753 cites W2052003026 @default.
• W2023333753 cites W2060726951 @default.
• W2023333753 cites W2061798392 @default.
• W2023333753 cites W2064574531 @default.
• W2023333753 cites W2064577051 @default.
• W2023333753 cites W2070775181 @default.
• W2023333753 cites W2073714468 @default.
• W2023333753 cites W2083018942 @default.
• W2023333753 cites W2084873146 @default.
• W2023333753 cites W2093248268 @default.
• W2023333753 cites W2094265649 @default.
• W2023333753 cites W2109584387 @default.
• W2023333753 cites W2116030648 @default.
• W2023333753 cites W2126329442 @default.
• W2023333753 cites W2135857271 @default.
• W2023333753 cites W2138939191 @default.
• W2023333753 cites W2139453048 @default.
• W2023333753 cites W2142644111 @default.
• W2023333753 cites W2168367599 @default.
• W2023333753 cites W2170115895 @default.
• W2023333753 cites W2170298556 @default.
• W2023333753 cites W4237954786 @default.
• W2023333753 cites W4246693888 @default.
• W2023333753 doi "https://doi.org/10.1016/j.nucmedbio.2004.03.012" @default.
• W2023333753 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15464396" @default.
• W2023333753 hasPublicationYear "2004" @default.
• W2023333753 type Work @default.
• W2023333753 sameAs 2023333753 @default.
• W2023333753 citedByCount "25" @default.
• W2023333753 countsByYear W20233337532012 @default.
• W2023333753 countsByYear W20233337532013 @default.
• W2023333753 countsByYear W20233337532014 @default.
• W2023333753 countsByYear W20233337532015 @default.
• W2023333753 countsByYear W20233337532016 @default.
• W2023333753 countsByYear W20233337532017 @default.
• W2023333753 countsByYear W20233337532018 @default.
• W2023333753 countsByYear W20233337532020 @default.
• W2023333753 crossrefType "journal-article" @default.
• W2023333753 hasAuthorship W2023333753A5013653576 @default.
• W2023333753 hasAuthorship W2023333753A5016514269 @default.
• W2023333753 hasAuthorship W2023333753A5018313627 @default.
• W2023333753 hasAuthorship W2023333753A5020722287 @default.
• W2023333753 hasAuthorship W2023333753A5029786366 @default.
• W2023333753 hasAuthorship W2023333753A5053572621 @default.
• W2023333753 hasAuthorship W2023333753A5071624932 @default.
• W2023333753 hasAuthorship W2023333753A5083715547 @default.
• W2023333753 hasAuthorship W2023333753A5087635866 @default.
• W2023333753 hasConcept C116569031 @default.
• W2023333753 hasConcept C126322002 @default.
• W2023333753 hasConcept C134018914 @default.
• W2023333753 hasConcept C150903083 @default.
• W2023333753 hasConcept C169760540 @default.
• W2023333753 hasConcept C170493617 @default.
• W2023333753 hasConcept C178790620 @default.
• W2023333753 hasConcept C185592680 @default.
• W2023333753 hasConcept C207001950 @default.
• W2023333753 hasConcept C2776359302 @default.
• W2023333753 hasConcept C2777348757 @default.
• W2023333753 hasConcept C2778897929 @default.
• W2023333753 hasConcept C2779652256 @default.
• W2023333753 hasConcept C2780062018 @default.
• W2023333753 hasConcept C513476851 @default.
• W2023333753 hasConcept C55493867 @default.
• W2023333753 hasConcept C61174792 @default.
• W2023333753 hasConcept C67018056 @default.

• next